Yabao Pharmaceutical Group Co Ltd (600351) — Financial Flexibility Index
Yabao Pharmaceutical Group Co Ltd (600351) has a Financial Flexibility Index of 0.23x as of September 2025. Free cash flow of CN¥137.07 Million (operating CF CN¥129.49 Million minus capex CN¥7.58 Million) represents 0% of total liabilities (CN¥585.77 Million). Check how aggressively does Yabao Pharmaceutical Group Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Yabao Pharmaceutical Group Co Ltd Financial Flexibility Index (2001–2024)
Historical Financial Flexibility Index trend for Yabao Pharmaceutical Group Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see 600351 cash flow conversion.
Annual Financial Flexibility Index for Yabao Pharmaceutical Group Co Ltd (2001–2024)
Year-by-year free cash flow to debt coverage for Yabao Pharmaceutical Group Co Ltd. Explore cash flow to debt ratio of Yabao Pharmaceutical Group Co Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.78x | CN¥506.36 Million | CN¥471.69 Million | CN¥649.02 Million | ▲ +12.4% |
| 2023 | 0.69x | CN¥597.41 Million | CN¥497.55 Million | CN¥860.33 Million | ▲ +49.4% |
| 2022 | 0.46x | CN¥522.69 Million | CN¥460.46 Million | CN¥1.12 Billion | ▼ -2.8% |
| 2021 | 0.48x | CN¥532.56 Million | CN¥437.50 Million | CN¥1.11 Billion | ▲ +28.9% |
| 2020 | 0.37x | CN¥443.83 Million | CN¥380.96 Million | CN¥1.20 Billion | ▲ +1.2% |
| 2019 | 0.37x | CN¥582.26 Million | CN¥425.17 Million | CN¥1.59 Billion | ▲ +34.4% |
| 2018 | 0.27x | CN¥494.61 Million | CN¥426.60 Million | CN¥1.81 Billion | ▲ +51.9% |
| 2017 | 0.18x | CN¥261.07 Million | CN¥161.73 Million | CN¥1.45 Billion | ▲ +10.2% |
| 2016 | 0.16x | CN¥240.42 Million | CN¥155.95 Million | CN¥1.48 Billion | ▲ +4.6% |
| 2015 | 0.16x | CN¥245.14 Million | CN¥143.47 Million | CN¥1.57 Billion | ▼ -39.7% |
| 2014 | 0.26x | CN¥352.47 Million | CN¥178.63 Million | CN¥1.37 Billion | ▲ +149.6% |
| 2013 | 0.10x | CN¥155.82 Million | CN¥56.80 Million | CN¥1.51 Billion | ▲ +1383.4% |
| 2012 | 0.01x | CN¥8.85 Million | CN¥-96.73 Million | CN¥1.27 Billion | ▼ -95.2% |
| 2011 | 0.14x | CN¥160.28 Million | CN¥40.73 Million | CN¥1.11 Billion | ▲ +0.1% |
| 2010 | 0.14x | CN¥205.87 Million | CN¥18.57 Million | CN¥1.43 Billion | ▼ -70.4% |
| 2009 | 0.49x | CN¥638.39 Million | CN¥368.56 Million | CN¥1.31 Billion | ▲ +64.1% |
| 2008 | 0.30x | CN¥250.46 Million | CN¥102.90 Million | CN¥843.93 Million | ▲ +50.4% |
| 2007 | 0.20x | CN¥136.99 Million | CN¥105.69 Million | CN¥694.23 Million | ▲ +141.2% |
| 2006 | 0.08x | CN¥55.29 Million | CN¥11.59 Million | CN¥675.74 Million | ▼ -52.8% |
| 2005 | 0.17x | CN¥135.35 Million | CN¥26.40 Million | CN¥780.42 Million | ▼ -63.2% |
| 2004 | 0.47x | CN¥282.54 Million | CN¥79.73 Million | CN¥599.65 Million | ▲ +122.1% |
| 2003 | 0.21x | CN¥73.55 Million | CN¥-9.62 Million | CN¥346.67 Million | ▼ -30.4% |
| 2002 | 0.30x | CN¥51.67 Million | CN¥24.29 Million | CN¥169.57 Million | ▲ +10.8% |
| 2001 | 0.27x | CN¥46.63 Million | CN¥23.59 Million | CN¥169.58 Million | — |